Riskpilot← Back to searchSign inGet full accessRebiome A/S
A/SActiveCVR 41002212Svanemøllevej 11Wholesale of perfume and cosmetics · NACE 4645Est. 2019— employees
Revenue 2025
DKK 65K
-87% vs 2024
EBITDA margin
100.0%
-87% vs 2024
Equity ratio
65.6%
Financial strength
Net profit 2025
DKK 35K
-91% vs 2024
| Revenue | DKK 65K | -87% |
| EBITDA | DKK 65K | -87% |
| Net profit | DKK 35K | -91% |
| Total assets | DKK 1,6M | +18% |
| Equity | DKK 1M | +4% |
| Employees | — | — |
Legal name
Rebiome A/S
CVR number
41002212
Legal form
Aktieselskab
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
1. december 2019
Share capital
DKK 500.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller af to bestyrelsesmedlemmer i forening med en direktør.
Company purpose
Selskabets formål er at drive handel og produktion af kosmetiske produkter samt, at drive anden virksomhed, der efter bestyrelsens skøn er forbundet hermed.
Address
Svanemøllevej 11
Phone
+4536306444
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | -515 | -110 | -227 | 428 | 493 | 65 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -515 | -110 | -227 | 428 | 493 | 65 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -515 | -110 | -227 | 428 | 493 | 65 |
| Net financials | 0 | -27 | -42 | 10 | 4 | -20 |
| Profit before tax | -515 | -137 | -269 | 438 | 497 | 45 |
| Tax | -113 | -30 | -0 | 44 | 109 | 10 |
| Net profit | -402 | -107 | -269 | 394 | 388 | 35 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 1.045 | 2.158 | 1.112 | 959 | 1.343 | 1.583 |
| Equity | 598 | 491 | 222 | 616 | 1.004 | 1.039 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 447 | 1.667 | 890 | 343 | 339 | 544 |
| Total debt | 447 | 1.667 | 890 | 343 | 339 | 544 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202025
Equity ratio
65.6%
This company
38.2%
Market median
+72% vs market
20202025
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
20202025
Net profit margin
53.9%
This company
8.1%
Market median
+565% vs market
20202025
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
20202025
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20202025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-12-01 – 2020-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RA Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
TS Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
PM Management | Management | 2019 | — | — |
KS Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
TP Chief Executive Officer | Chief Executive Officer | 2026 | — | — |
JM Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PRO-MEDUC GROUP A/S | Company | 100.0% | 100.0% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pro-Meduc Holding A/S
Rebiome A/S Board members of Rebiome A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ronni Aaberg Jansen | Chief Executive Officer | 0 companies |
| Titus Sixten Hinsch Gylvin | Chief Executive Officer | 0 companies |
| Pernille Mette Ritlov | Management | 0 companies |
| Klaus Spärck Abel | Chief Executive Officer | 0 companies |
| Tine Pauline Sell Hellmann | Chief Executive Officer | 0 companies |
| Jakob Mohr Christensen | Chief Executive Officer | 0 companies |
| Sanne Wall-Gremstrup | Chairman | 0 companies |
| Amalie Victoria Sell Hellmann | Board of Directors | 0 companies |